Physician
Cardiology
Dr. Brian Lowes, MD
|
|
Give Review
Brian Lowes works in the field of Cardiology. He went to Wayne State University School of Medicine. Wayne State University School of Medicine is ranked 63/85 in Research/PrimaryCare. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Brian Lowes is a published doctor. He published 64 publications, including: 'The role of third-generation beta-blocking agents in chronic heart failure.' Doctor Brian Lowes, MD is registered with Medicare.
Publications
- Therapeutic Molecular Phenotype of β-blocker Associated Reverse-Remodeling in Nonischemic Dilated Cardiomyopathy.
- Timed response to inhaled nitric oxide in Pulmonary hypertension.
- Worsening Renal Function in Patients with Acute Decompensated Heart Failure Treated with Ultrafiltration: Predictors and Outcomes.
- Association of DJ-1/PTEN/AKT- and ASK1/p38-mediated cell signalling with ischaemic Cardiomyopathy.
- Cytomegalovirus reactivation and colitis after left ventricular assist device placement.
- Angiotensin-converting enzyme DD genotype in patients with primary Pulmonary hypertension: increased frequency and association with preserved haemodynamics.
- The effect of diabetes on outcomes of patients with advanced Heart failure in the BEST trial.
- Peak oxygen consumption and outcome in heart failure patients Chronically treated with beta-blockers.
- Drug therapy in the Heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs.
- Drug therapy in the Heart transplant recipient: part II: immunosuppressive drugs.
- BOOP is common in cardiac transplant recipients switched from a calcineurin inhibitor to sirolimus.
- Molecular remodeling in the failing human Heart.
- Rationale and design of the enoximone clinical trials program.
- Serial gene expression profiling in the intact human Heart.
- Gene expression profile of the recovering human Heart.
- Baseline and serial neurohormones in patients with congestive Heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Block...
- Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intraVenous inotropic support: results of the oral enoximone in in...
- Quality of life and prognosis in Heart failure: results of the Beta-Blocker Evaluation of Survival Trial (BEST).
- Assist devices fail to reverse patterns of fetal gene expression despite beta-blockers.
- Genetic determinants of drug response in Heart failure.
- Possible Heart failure exacerbation associated with pregabalin: case discussion and literature review.
- Left ventricular assist device as bridge to transplantation does not adversely affect one-year Heart transplantation survival.
- Myocardial protection in sepsis.
- An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in Chronic heart failure.
- Rationale and design of the treatment of hyponatremia based on Lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study.
- Incomplete Recovery of Myocyte Contractile Function Despite Improvement of Myocardial Architecture With Left Ventricular Assist Device Support.
- Myocardial FFA metabolism during rest and Atrial pacing in humans.
- Myocardial glucose and lactate metabolism during rest and Atrial pacing in humans.
- Overdrive pacing suppresses ectopy and minimizes left ventricular assist device suction events.
- Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic Heart failure with QRS prolongation: COMPANIO...
- Drug therapy in the Heart transplant recipient: Part III: common medical problems.
- Echocardiographic predictors of morbidity and mortality in patients with advanced Heart failure: the Beta-blocker Evaluation of Survival Trial (BEST).
- Hormone replacement therapy is associated with improved survival in women with advanced Heart failure.
- Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial.
- Low-dose enoximone improves exercise capacity in Chronic heart failure. Enoximone Study Group.
- Predicting response to carvedilol for the treatment of Heart failure: a multivariate retrospective analysis.
- Inotropes and beta-blockers: is there a need for new guidelines?
- Aspirin impairs reverse myocardial remodeling in patients with Heart failure treated with beta-blockers.
- Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced Heart failure.
- Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated hea...
- Right ventricular phenotypic characteristics in subjects with primary pulmonary hypertension or idiopathic dilated Cardiomyopathy.
- Patient preferences for Heart failure treatment: utilities are valid measures of health-related quality of life in Heart failure.
- Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in Chronic heart failure.
- Second- and third-generation beta-blocking drugs in Chronic heart failure.
- Milrinone versus dobutamine in heart failure subjects treated Chronically with carvedilol.
- Beta-blockade in adriamycin-induced Cardiomyopathy.
- Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV Heart failure.
- The role of third-generation beta-blocking agents in Chronic heart failure.
- Angiotensin II formation in the intact human Heart. Predominance of the angiotensin-converting enzyme pathway.
- Inotropes in the beta-blocker era.
- Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol.
- Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated Cardiomyopathy phenotype.
- Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated Cardiomyopathy.
- Acute parvovirus infection in a heart transplant recipient.
- Low-dose inotropic therapy for ambulatory Heart failure.
- Importance of angiotensin-converting enzyme in Pulmonary hypertension.
- Changes in gene expression in the intact human Heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.
- Prevalence of depression in congestive Heart failure.
- Dilated Cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin.
- The pressure-overloaded right ventricle in Pulmonary hypertension.
- Left ventricular assist device effects on metabolic substrates in the failing Heart.
- Myocardial gene expression in dilated Cardiomyopathy treated with beta-blocking agents.
- Altered expression of endothelin receptors in failing human left ventricles.
Schools
Wayne State University School Of Medicine
University Of Colorado Denver
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Acute Venous Embolism Thrombosis
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- Coventry Health Care of Nebraska PPO
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- Mutual of Omaha
- Thrivent Financial
- Choice Plus POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Colorado -
Wayne State University School of Medicine
Hospital
-
University of Colorado Hospital
Drug Facts
| NPI NUMBER | 1518057298 | |
| NPPES Provider LastName | LOWES | |
| NPPES Provider FirstName | BRIAN | |
| NPPES Provider ZIPCode | 802044507 | |
| NPPES Provider State | CO | |
| Specialty Description | Cardiology | |
| Total Claim Count | 394.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1518057298 |
| Last Name Of The Provider | LOWES |
| First Name Of The Provider | BRIAN |
| View All |
Similar Doctors
|
Dr. Peter J. Kriekard, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Nelson A. Prager, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. John D. Carroll, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle S. Khoo, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Larry A. Allen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andreas Brieke, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Peter Buttrick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amber Khanna, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara Abrahams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence D. Horwitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Orhan Sancaktar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dominik M. Wiktor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rhonda L. Miyasaka, MD
This Doctor is OpenDoctor Recommended.
|